ESPR   $1.69  -3.43% Market Closed After Close 1.71 1.18%

Esperion Therapeutics Inc
Total Cash 189.30M
totalCashPerShare 0.965
EBITDA 4.99M
Total Debt 269.14M
quickRatio 1.424
currentRatio 1.968
Total Revenue 277.79M
debtToEquity
Revenue/Share 1.907
ROA 0.01054
ROE
grossProfits
freeCashflow 6.91M
operatingCashflow -9.76M
earningsGrowth
revenueGrowth 1.863
grossMargins 0.6112
ebitdaMargins 0.01796
operatingMargins 0.034930002
profitMargins -0.35458001
enterpriseValue 454.62M
forwardPE 7.64
floatShares 194.83M
sharesOutstanding 196.22M
sharesShort 40.44M
sharesShortPriorMonth 38.14M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.71%
Short Ratio help_outline 9.25%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue -1.769
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -98.50M
trailingEps -0.85%
forwardEps 0.25%
enterpriseToEbitda 91.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 209
lastUpdated Sept. 16, 2024, 11:58 a.m.